Kamal Hamed

Kamal Hamed

Nessuna posizione attualmente
65 anni
Health Technology
Consumer Services

Profilo

Kamal Hamed currently works at Spero Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Hamed also formerly worked at Novartis, Inc., as Head-Therapeutic Area from 2005 to 2017, Basilea Pharmaceutica AG, as Head-Clinical Development & Medical Affairs from 2017 to 2022, and Lysovant Sciences, Inc., as Chief Medical Officer in 2022.
Dr. Hamed received his graduate degree from The Johns Hopkins University, Masters Business Admin degree from the University of South Florida, and doctorate degree from American University of Beirut.

Precedenti posizioni note di Kamal Hamed

SocietàPosizioneFine
SPERO THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S 01/08/2024
Lysovant Sciences, Inc.
Direttore Tecnico/Scientifico/R&S 01/08/2022
BASILEA PHARMACEUTICA AG Direttore Tecnico/Scientifico/R&S 01/02/2022
Corporate Officer/Principal 01/03/2017
Vedi nel dettaglio l'esperienza di Kamal Hamed

Formazione di Kamal Hamed

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

9

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Lysovant Sciences, Inc.

  1. Mercati
  2. Insiders
  3. Kamal Hamed